Narrow Your Results

Aura Biosciences announced promising safety and efficacy outcomes in a phase 1b/2 trial for AU-011, their first-in-class therapy for primary choroidal melanoma.

This prospective, multicenter study compared ophthalmoscopy with telemedicine for diagnosing retinopathy of prematurity (ROP).

In this study, the authors describe a novel technique for the treatment of keratoconus using femtosecond-assisted corneal allogenic intrastromal ring segments (CAIRS).

Ocutrx Vision Technologies has patented the technology behind their augmented reality glasses for low-vision patients.

This prospective study describes the etiology of people with uveitis who are living South Africa.

This is the first study to evaluate long-term outcomes of patients who underwent surgery for symptomatic epiretinal membrane (ERM), with or without ILM peeling.

Using OCT angiography, investigators measured the peripapillary perfused capillary density (PCD) in patients with myopia and open-angle glaucoma.

In this retrospective case series, investigators analyzed vitreoretinal complications and treatment outcomes in eyes undergoing modified osteo-odonto-keratoprosthesis (OOKP) surgery.

This study retrospectively compared retinal hemorrhages (RHs) in infants who experienced abusive head trauma (AHT) versus infants who had normal vaginal deliveries (NVD).

In this study, researchers measured spontaneous improvements that occurred in patients who were treated conservatively for blowout fractures.

This week, a low-power ultrafast laser aims to usurp corneal refractive surgeries, tennis star Venus Williams endorses Alcon’s Systane Complete drops and an aflibercept-suprachoroidal steroid combo could reduce treatment frequency in patients with diabetic macular edema.

This study compares the efficacy of topical steroids in patients with dry eye disease (DED) who do or do not have underlying graft-vs-host disease (GVHD).

In this prospective study, researchers compared the progression of primary open-angle glaucoma (POAG) in patients with or without type 2 diabetes.

New findings suggest a low-carb, high-fat diet may guard against glaucoma—at least in mice.

This prospective study suggests that immunocytology using BRCA-1 associated protein 1 (BAP1) could aid prognostication of uveal melanoma.

This single-center retrospective study examined rates of loss to follow-up in patients with proliferative diabetic retinopathy (PDR) who had received laser photocoagulation or intravitreal anti-VEGF injections.

The MINIject glaucoma device from iSTAR Medical is showing promising results in treating patients with mild to moderate primary open-angle glaucoma after 6 months of clinical trials.

This week, miniature telescope implants make their way across the nation to serve veterans with AMD, a new hydrogel coats the cornea with cannabinoids and a cleaner, CRISPR editing system restores retinal function in mice.

This study suggests that diffusion-weighted imaging can effectively distinguish nonthrombosed distensible venous malformations of the orbit from other orbital tumors.

This review of data from the Physician Insurers Association of America professional liability registry examined claims against ophthalmologists over a 10-year period.

This week, Valeant Pharmaceuticals rebrands itself as Bausch Health Companies, the Ebola virus selectively attacks photoreceptors and a chip-based neuronal network shows light damage rippling through the retina.

This secondary analysis of the Mycotic Ulcer Treatment Trial II (MUTT II) found that patients with a positive 6-day fungal culture carry a high risk of corneal perforation.

Takeda Pharmaceuticals has reached an agreement to purchase Dublin-based Shire and its dry eye drug, lifitegrast (Xiidra).

In this retrospective analysis, the authors review the etiology and vision outcomes of patients with dilated superior ophthalmic vein (SOV).

This international retrospective study evaluated the risk of extraocular extension in retinoblastoma patients after intravitreal chemotherapy.